|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
35
|
|
pubmed:dateCreated |
2008-12-10
|
|
pubmed:abstractText |
Human epidermal growth factor receptor 2 gene (HER2) is associated with a poorer outcome in node-positive breast cancer, but the results are conflicting in node-negative disease. This study assessed the prognostic impact of HER2 overexpression/amplification in a large series of node-negative breast cancers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5697-704
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19001334-Aged,
pubmed-meshheading:19001334-Antibodies, Monoclonal,
pubmed-meshheading:19001334-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:19001334-Antineoplastic Agents,
pubmed-meshheading:19001334-Breast Neoplasms,
pubmed-meshheading:19001334-British Columbia,
pubmed-meshheading:19001334-Chemotherapy, Adjuvant,
pubmed-meshheading:19001334-Disease-Free Survival,
pubmed-meshheading:19001334-Female,
pubmed-meshheading:19001334-Humans,
pubmed-meshheading:19001334-Kaplan-Meier Estimate,
pubmed-meshheading:19001334-Middle Aged,
pubmed-meshheading:19001334-Neoplasm Invasiveness,
pubmed-meshheading:19001334-Neoplasm Staging,
pubmed-meshheading:19001334-Proportional Hazards Models,
pubmed-meshheading:19001334-Receptor, erbB-2,
pubmed-meshheading:19001334-Receptors, Estrogen,
pubmed-meshheading:19001334-Risk Assessment,
pubmed-meshheading:19001334-Time Factors,
pubmed-meshheading:19001334-Tissue Array Analysis,
pubmed-meshheading:19001334-Treatment Outcome,
pubmed-meshheading:19001334-Up-Regulation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
|
|
pubmed:affiliation |
Division of Medical Oncology, Breast Cancer Outcomes Unit, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada. schia@bccancer.bc.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
